Maravai Lifesciences Holdings (MRVI) Total Debt (2020 - 2026)

Maravai Lifesciences Holdings' Total Debt history runs 7 years deep, the most recent figure standing at $241.0 million for Q1 2026.

• In Q1 2026, Total Debt fell 18.28% year-over-year to $241.0 million; the TTM figure through Mar 2026 stood at $241.0 million (down 18.28% YoY), while the FY2025 annual figure was $291.8 million, down 1.41% from the prior year.
• Total Debt was $241.0 million for Q1 2026 at Maravai Lifesciences Holdings, down from $291.8 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $746.0 million in Q3 2022 to a low of $241.0 million in Q1 2026.
• Historically, Total Debt has averaged $466.7 million across 5 years, with a median of $523.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Debt jumped 45.77% in 2022, then tumbled 43.87% in 2025.
• A 5-year view of Total Debt shows it stood at $527.4 million in 2022, then fell by 0.62% to $524.1 million in 2023, then plunged by 43.54% to $295.9 million in 2024, then decreased by 1.41% to $291.8 million in 2025, then retreated by 17.4% to $241.0 million in 2026.
• The last three Total Debt figures came in at $241.0 million (Q1 2026), $291.8 million (Q4 2025), and $292.8 million (Q3 2025), per Business Quant data.